Patients Fear Spike in Price of Old DrugsNew York Times“The Orphan Drug Act was intended to promote new drug development, not price gouging of old drugs,” Dr. Makary said. Catalyst’s chief executive, Patrick J. McEnany, said in an interview that the company would offer financial assistance to any patients …and more …read more From:: New […]
from WordPress http://ift.tt/1ZoXEIC
via IFTTT
0 comments:
Post a Comment